Skip to content

Clinical observation on the therapeutic effect of 'three-part acupoint combination' combined with Aili eye drops in the treatment of perimenopausal dry eye syndrome.

Clinical observation on the therapeutic effect of 'three-part acupoint combination' combined with Aili eye drops in the treatment of perimenopausal dry eye syndrome.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003938
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye disease

Interventions

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the above diagnostic criteria of perimenopausal dry eye with deficiency of liver and kidney Yin; (2) If the western medicine eye drops are used for treatment before enrollment, the drug should be stopped for at least three weeks or more; in addition, the patient has not participated in other therapies or other clinical studies within three months; (3) Non-allergic constitution; (4) Voluntary participation and signing of informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with other eye diseases, such as congenital tear deficiency, lacrimal duct obstruction, severe trachoma, keratopathy, conjunctival scarring, conjunctival lesions and other eye diseases, and subjects undergoing eye surgery; (2) Combined with dry mouth, joint pain and dry skin, considered as sjogren's syndrome caused by dry eyes; (3) Subjects during pregnancy and lactation; (4) Subjects with severe systemic diseases, such as cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, and coagulation dysfunction; (5) Subjects with mental disorders or psychological disorders who cannot cooperate with the treatment and study; (6) Contact lens wearer.

Design outcomes

Primary

MeasureTime frame
BUT;FL;Schirmer test;

Secondary

MeasureTime frame
sex hormone;

Countries

China

Contacts

Public Contactkaiyong Zhang

Shanghai General Hospital

zhangkaiyong1983@163.com+86 13564895234

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026